scispace - formally typeset
G

Giuseppe Mancia

Researcher at University of Milano-Bicocca

Publications -  1465
Citations -  152794

Giuseppe Mancia is an academic researcher from University of Milano-Bicocca. The author has contributed to research in topics: Blood pressure & Ambulatory blood pressure. The author has an hindex of 145, co-authored 1369 publications receiving 139692 citations. Previous affiliations of Giuseppe Mancia include University of Milan & Instituto Politécnico Nacional.

Papers
More filters
Journal ArticleDOI

Left ventricular geometry, ambulatory blood pressure and extra-cardiac organ damage in untreated essential hypertension

TL;DR: Findings indicate that LV geometric patterns reflect different degrees of BP load and subclinical extra-cardiac alterations and may be regarded, in addition to absolute values of LV mass, as a reliable marker of cardiovascular (CV) risk.
Journal ArticleDOI

Combination of lisinopril and nifedipine GITS increases blood pressure control compared with single drugs in essential hypertensive patients.

TL;DR: Antihypertensive treatment with the combination of lisinopril and nifedipine GITS is more effective and balanced over the 24 hours than the combination components administered alone, confirming that the smoothness index is superior to the trough-to-peak ratio in assessing homogeneity of pharmacologic blood pressure reduction.
Journal ArticleDOI

Blood pressure variability and reflex control in the elderly

TL;DR: This paper will examine how aging affects baroreceptor control of the heart and sympathetic nerve traffic, providing evidence that while the former is markedly impaired in the elderly, the latter is virtually preserved.
Journal ArticleDOI

Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension

TL;DR: Accumulating evidence suggests an adverse prognosis associated with night-time hypertension, nondipping blood pressure (BP) profile and morning BP surge, with increased incidence of cardiovascular events during the first few morning hours, providing justification for complete 24-h BP control as being the primary goal of antihypertensive treatment.